Frontlight ResearchEarly access
Trial site
University of Alabama at Birmingham, Comprehensive Cancer Center
- 5running trials
- 4closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Childhood cancers3 trials
- Lung cancer2 trials
- Multiple myeloma2 trials
- Sarcoma2 trials
- Brain metastases1 trial
- Chronic lymphocytic leukaemia1 trial
- Mantle cell lymphoma1 trial
- Myeloproliferative neoplasms1 trial
- Phase
- Phase 24 trials
- Phase 1/23 trials
- Phase 32 trials
- Status
- Active, not recruiting3 trials
- Completed3 trials
- Not yet recruiting1 trial
- Recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Incyte Corporation3 trials
- H. Lee Moffitt Cancer Center and Research Institute2 trials
- Janssen Research & Development, LLC2 trials
- American Society of Clinical Oncology1 trial
- NovoCure GmbH1 trial
Running trials
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Childhood cancers1 recruiting
- Multiple myeloma1 recruiting
- Myeloproliferative neoplasms1 recruiting
Closed trials
Terminated
Completed
Completed
Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma
Completed
Site data: ClinicalTrials.govUpdated 14 Nov 2026